We have received confirmation that our final report in the ACTTiVAte project has been accepted. This marks the end of this stage of works on BubbleFoot – a device for diabetic foot carboxytherapy with the use of micro- and nanobubble technology (MNB). The support we received from the ACTTiVAte project was manifold. In addition to the financial grant, it included training, workshops and mentoring, the value of which is invaluable to us.
We intend to work on and refine the product we built the prototype of. We are also looking for an investor who would wish to co-finance its commercialization. We see a place on the market for four technologically related device groups, targeted at slightly different recipients – from individual users, through wellness & SPA rooms, physiotherapeutic practices, to hospitals and outpatient clinics. The benefit for patients who, thanks to using BubbleFoot, can avoid painful ailments or even amputations, would be huge.
We have been implementing a project for the European Space Agency (ESA) since January. We have been selected as a subcontractor of Creotech Instruments S.A. to carry out a research and development project whose aim is to develop a device for contactless removal of molecular contamination from the surface of satellite components before sending them into space. Creotech is responsible for developing the general concept of the device, its mechanical parts and sub-systems related to the feeding and collection of the cleaning agent. Our task is to produce the cleaning agent and to perform the necessary analyses – both of the cleaned surface and the collected contaminants.
Requirements set by ESA are very difficult to meet, and the device would replace the methods used so far, based on the use of aggressive chemicals, with the use of water with gas nanobubbles. Due to the need to avoid secondary contamination of the surface by cleaning agent residues (e.g., stains), we intend to use the so-called ultrapure water and gas subjected to multistage filtration.
The preliminary design work, constituting the content of the first stage, was accepted by ESA during the System Requirements Review (SRR), and we proceeded to the implementation of the second stage, in which we will design laboratory testing facilities.
Our proposed “BubbleFoot” project has been qualified for financing as part of the ACTTiVAte program. The project concerns preparation of the commercialisation of a diabetic foot cabroxytharapy device. Soaking feet in water with nano-bubbles of carbon dioxide can lower the risk or recurrence of the unpleasant ailment as much as sevenfold.